Evolution Spine is engaged in the design, manufacturing and sales of medical implants, instruments and biologic materials. The Company’s products are used in the treatment of orthopedic and neurological surgical procedures such as degenerative spine disease, spine trauma, and correction of spinal deformities such as scoliosis. Based in Dallas, Texas, the Company was founded with the desire to supply premier products to spine surgeons and hospitals by providing best in class products, flawless service, and the desire to innovate. The Company has positioned itself to be very responsive to individual surgeon needs for implant design or instrumentation that improves operating theater workflow. The Company initially focused on developing a core product portfolio of PEEK interbody products based upon market-embraced predicate designs. Product development efforts are now focused on creating the next generation of products and instrumentation, using advanced production methods such as additive manufacturing. These designs strike the perfect balance of increasing implant stabilization while maintaining features that promote robust fusion. The Company is also a focused on incorporating innovative coatings and packaging that reduce infection potential, and is working closely with leading academic institutions to bring new concepts to market. http://evolutionspine.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.
Source: marketsandmarkets.com